HCMT
GWPH

Highland Capital Management (Texas)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Highland Capital Management (Texas)’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$6.05M – 354
2017
Q1 		$6.05M Buy
+50,000
New +$6.13M 0.31% 83

Other funds holding GWPH

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Highland Capital Management (Texas)'s GWPH Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 35,500 shares — an estimated $3.6M sold.

Highland Capital Management (Texas) first reported a position in GWPH in Q2 2014 and held it in 5 quarters. The position peaked at $9.38M in Q2 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

  • Highland Capital Management (Texas) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 35,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $3.6M.
  • Highland Capital Management (Texas) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 5 quarters.
  • Highland Capital Management (Texas)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.38M in Q2 2017.
  • 204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.